⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
prnewswire.com
GSK
Smart Inhalers Market to Reach $12.1 Billion by 2030, Driven by Poor Medication Adherence Crisis
globenewswire.com
AZN
GSK
NVS
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
globenewswire.com
ATAI
DSGR
CCRN
NUVL
DAN
LLY
GSK
ETN
ENT Disorder Treatment Market to Reach US$58 Billion by 2034, Driven by Digital Diagnostics and Minimally Invasive Car
globenewswire.com
GSK
SNY
PFE
AZN
NVS
ABBV
JNJ
MRK
MDT
SN
BSX
TEVA
SUN
CData Extends Connect AI to HIPAA-Regulated Healthcare
prnewswire.com
GSK
DBX
MSFT
GOOG
PLTR
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape
globenewswire.com
AMGN
AZN
JNJ
NVS
ABBV
AKBA
ARDX
CHNR
LLY
FGEN
GILD
GSK
NVO
PFE
Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL
businesswire.com
GSK
NUVL
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
globenewswire.com
JNJ
BNTX
CUE
GMAB
IMPP
INO
AZN
GSK
MRK
BMY
EXEL
REGN
PDSB
IOVA
RPTX
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
prnewswire.com
BIIB
RPRX
UCB
VTRS
NVS
KZR
GSK
AZN
ABBV
BMY
JNJ
Drug-Delivery Technology Market Report 2026
globenewswire.com
MRK
ABBV
SNY
AZN
NVS
GSK
TEVA
REGN
VRTX
ALKS
HALO